TORONTO, ONTARIO – TheNewswire - August 24, 2021 – A-Labs Capital V Corp. (TSXV:ALBA.P) (the "Company") is pleased to announce that it has completed its initial public offering (the "Offering") in British Columbia, Alberta and Ontario of 2,750,000 common shares (the "Common Shares") in the capital of the Company at a price of $0.10 per Common Share for gross proceeds of $275,000.  Following the closing of the Offering today, a total of 6,651,281 Common Shares were issued and outstanding, of which, 3,901,281 are currently held in escrow pursuant to the policies of the TSX Venture Exchange (the "TSXV").

The net proceeds of the Offering, together with the proceeds from prior sales of Common Shares will be used by the Company to identify and evaluate assets or businesses for acquisition with a view to completing a "Qualifying Transaction" under the capital pool company program of the TSXV.

Haywood Securities Inc. (the "Agent") acted as agent for the Offering.  In connection with the Offering, the Company paid to the Agent a cash commission of $22,000, equal to 8% of the aggregate gross proceeds of the Offering and granted to the Agent 275,000 non-transferrable share purchase warrants (the "Agent's Warrants"), equal to 10% of the number of Common Shares delivered by the Agent pursuant to the Offering. Each Agent Warrant entitles the holder thereof to acquire one Common Share at a price of $0.10 per Common Share for a period of 60 months from the date the Common Shares are listed on the TSXV.

At the closing of the Offering, the Company also granted stock options (the "Options") to directors and officers of the Company to acquire up to an aggregate of 665,128 Common Shares (of which 156,052 Options are exercisable at a price of $0.05 per share until June 11, 2031 and 509,076 Options are exercisable at a price of $0.10 per share until August 24, 2031).

The current directors and officers of the Company are: Rita Alter, Chief Executive Officer, Secretary and Director; Yosef Shemesh, Chief Financial Officer and Director; Jason Saltzman, Director; Hillar Lilles, Director; and Wayne Miller, Director.

The Common Shares will commence trading on the TSXV under the stock symbol "ALBA.P" starting today.

In addition, Ms. Rita Alter, the chief executive officer, secretary and a director of the Company announces that she has filed an early warning report announcing that on August 24, 2021, on closing of the Offering, the Company granted to Ms. Alter 133,024 Options to acquire 133,024 Common Shares of the Company. Prior to the closing of the Offering, Ms. Alter owned and controlled 1,572,000 Common Shares representing approximately 40.29% of the outstanding Common Shares on a non-diluted basis.

Following closing of the Offering and this grant of Options, Ms. Alter now owns and controls 1,572,000 Common Shares and 133,024 Options to acquire 133,024 Common Shares, representing approximately 23.63% of the outstanding Common Shares of the Company on a non-diluted basis and approximately 25.13% on a partially diluted basis assuming the exercise of all Options.

Closing of the Offering resulted in a partially diluted ownership change of greater than 2% and the filing of an early warning report.

The securities noted above are held for investment purposes. Ms. Alter has a long-term view of the investment and may acquire additional securities of the Company either on the open market or through private acquisitions or sell the securities on the open market or through private dispositions in the future depending on market conditions, reformulation of plans and/or other relevant factors.

A copy of the early warning report with respect to the foregoing will appear on the Company's profile on the System for Electronic Document Analysis and Retrieval ("SEDAR") at www.sedar.com.

For further information please see the prospectus of the Company dated June 11, 2021 filed on SEDAR or contact:

Rita Alter, Chief Executive Officer at (972) 545-4914 or rita@alabs.co.

The securities issued pursuant to the Offering have not been, nor will they be, registered under the United States Securities Act of 1933, as amended, and may not be offered or sold in the United States or to, or for the account or benefit of, U.S. persons absent registration or an applicable exemption from the registration requirements.  This press release shall not constitute an offer to sell or the solicitation of an offer to buy nor shall there be any sale of the securities in any State in which such offer, solicitation or sale would be unlawful.

Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

Notice Regarding Forward Looking Information

Certain information set forth in this press release may contain forward-looking information that involves substantial known and unknown risks and uncertainties, including the use of proceeds of the Offering. This forward-looking information is subject to numerous risks and uncertainties, certain of which are beyond the control of the Company, including, but not limited to, the impact of general economic conditions, industry conditions, and dependence upon regulatory approvals (both in Canada and internationally). Readers are cautioned that the assumptions used in the preparation of such information, although considered reasonable at the time of preparation, may prove to be imprecise and, as such, undue reliance should not be placed on forward looking information. The Company disclaims any intention or obligation to update or revise any forward-looking information whether as a result of new information, future events, or otherwise, except as may be required by applicable securities law.